For years, colorectal cancer was largely viewed as a disease affecting people in their 50s, 60s and beyond.

That assumption is becoming less reliable.

While colorectal cancer still occurs predominantly in older adults, several countries are reporting increasing incidence among younger adults, including people in their 30s and 40s. The World Health Organization now specifically recognises this changing pattern.

A major international analysis published in The Lancet Oncology examined cancer-registry data from 50 countries and territories. Rates of early-onset colorectal cancer, defined as diagnosis between ages 25 and 49, were increasing in 27 of the 50 populations studied.

The important message is not that every young person should fear colon cancer.

It is that age alone should no longer be used to dismiss persistent digestive symptoms.

What Is Early-Onset Colorectal Cancer?

Colorectal cancer develops in the colon or rectum, which together form a major part of the lower digestive system.

Many colorectal cancers begin when abnormal growths called polyps develop in the inner lining of the bowel. Certain polyps can gradually undergo changes that eventually lead to cancer.

When colorectal cancer is diagnosed before age 50, it is commonly referred to as early-onset colorectal cancer (EOCRC).

Although India has historically had lower population incidence rates than many Western countries, younger Indian patients are certainly affected. A study from a tertiary cancer centre in Eastern India examining patients aged 39 or younger found that the rectum was the most frequent tumour location among the young cases studied.

That does not mean India has the same early-onset cancer trend as every Western country. The data are still evolving. But it does mean colorectal cancer should not automatically be ruled out simply because a patient is young.

Why Is Colorectal Cancer Increasing in Younger Adults?

This is where accuracy matters.

Researchers do not yet have one proven explanation for the rise in early-onset colorectal cancer.

Several factors are being investigated, and it is likely that the answer involves a combination of lifestyle, metabolic, environmental, genetic and biological influences.

Changing Diet Patterns

Modern diets can contain more processed foods, processed meat, excess calories and fewer fibre-rich whole foods.

Dietary patterns high in processed and red meat and low in fruits and vegetables are recognised colorectal cancer risk factors.

This does not mean eating a particular food once causes cancer. Cancer develops through complex biological processes over time.

Sedentary Lifestyle and Obesity

Physical inactivity, overweight and obesity are also associated with increased colorectal cancer risk.

For many younger adults, daily life now involves long periods sitting at a desk, commuting, using screens and getting less routine physical activity.

These factors are relevant, but they still do not fully explain the rise in early-onset cases.

Smoking and Alcohol

Tobacco use and alcohol consumption are established modifiable risk factors for colorectal cancer.

Long-term exposure becomes particularly relevant when several risk factors occur together.

Family History and Genetics

Some young patients have a hereditary predisposition to colorectal cancer.

Conditions such as Lynch syndrome and familial adenomatous polyposis (FAP) can substantially increase risk and may result in cancer developing much earlier than usual.

Having a parent, sibling or child with colorectal cancer can also influence how a doctor assesses an individual’s risk and screening requirements.

Inflammatory Bowel Disease

People with long-standing inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease involving the colon can have an increased risk of colorectal cancer.

This is one reason regular gastroenterology follow-up is important for patients with chronic inflammatory bowel disease.

Could the Gut Microbiome Also Be Involved?

This is one of the more interesting areas of current colorectal cancer research.

A 2025 Nature study analysed colorectal cancers from different geographic regions and age groups. Researchers identified mutational signatures associated with colibactin, a genotoxic substance produced by certain strains of E. coli.

The colibactin-associated signature was 3.3 times more common in colorectal cancers diagnosed before age 40 than in cancers diagnosed after age 70. The researchers proposed that exposure to colibactin-producing bacteria early in life may contribute to some cases of early-onset colorectal cancer.

This is an important research development, but it is not yet proof that ordinary gut bacteria are the main cause of early-onset colorectal cancer.

It is a clue scientists are actively investigating, not something patients should try to self-treat with antibiotics, probiotics or “gut cleanses.”

The Warning Signs Younger Adults Should Not Ignore

One reason early-onset colorectal cancer can be challenging is that digestive symptoms are common in young adults.

Constipation may be blamed on diet. Blood may be assumed to be piles. Abdominal discomfort may be considered acidity or IBS.

Most of the time these symptoms will not mean cancer, but persistent or unexplained symptoms still require proper evaluation.

Important warning signs include:

• Blood in the stool or rectal bleeding
• A persistent change in bowel habits
• Ongoing constipation or diarrhoea without an obvious cause
• Persistent abdominal pain, cramping or bloating
• Unexplained weight loss
• Persistent fatigue or weakness
• Iron-deficiency anaemia
• A feeling that the bowel does not empty completely
• Unexplained changes in stool pattern that continue for several weeks

These symptoms overlap with many non-cancerous digestive disorders. Their presence does not diagnose colorectal cancer, but persistent symptoms should not be ignored purely because someone is 25, 30 or 40 years old.

“It’s Probably Just Piles” Can Be a Dangerous Assumption

Blood during bowel movements is frequently caused by common conditions such as piles or anal fissures.

But seeing blood does not tell you where it came from.

Bleeding can also originate from polyps, inflammatory bowel disease, diverticular disease or colorectal cancer.

This is why repeatedly self-treating rectal bleeding without identifying the cause can delay diagnosis.

A gastroenterologist can evaluate the pattern of bleeding, associated symptoms, age, family history, examination findings and whether further investigation is necessary.

How Is Colorectal Cancer Diagnosed?

Diagnosis does not begin by assuming someone has cancer.

It begins by investigating the symptoms.

Depending on the patient’s condition, evaluation may include blood tests, clinical examination, imaging and examination of the colon.

Colonoscopy

A colonoscopy allows the doctor to directly examine the inside of the colon and rectum using a flexible camera.

It can identify abnormalities including inflammation, polyps, bleeding sources and suspicious growths.

Importantly, colonoscopy can also allow tissue samples to be collected if an abnormal area is discovered. DrGastro offers colonoscopy evaluation in Ahmedabad for appropriate digestive indications.

Biopsy

If a suspicious lesion is identified, a small tissue sample may be taken and examined under a microscope.

The biopsy determines whether abnormal tissue is cancerous and helps establish the tumour type.

Imaging

If colorectal cancer is confirmed, tests such as CT or MRI may be required to determine the location and extent of disease.

Doctors call this staging, and it is essential because treatment is determined largely by how far the cancer has spread.

Why Early Detection Makes Such a Difference

Colorectal cancer treatment becomes more complex as the disease spreads.

When cancer is detected while it remains localised, surgical treatment may sometimes be sufficient or form the main part of treatment.

When lymph nodes or distant organs are involved, additional treatments may be required.

This is why recognising symptoms and investigating them appropriately can matter much more than trying to guess whether symptoms are serious at home.

WHO notes that outcomes are strongly related to the stage at diagnosis and that cancers detected earlier are generally more treatable.

How Is Colorectal Cancer Treated Today?

Modern colorectal cancer treatment is increasingly personalised.

Doctors no longer determine treatment purely from the words “colon cancer” or “rectal cancer.”

The plan depends on the tumour location, stage, pathology, molecular characteristics and the patient’s overall health.

Surgery

For many early-stage colorectal cancers, surgery remains the main treatment.

The affected section of the colon or rectum and nearby lymph nodes may be removed.

Advances in laparoscopic and other minimally invasive surgical techniques mean that suitable patients may undergo treatment through smaller incisions rather than traditional open surgery.

However, the best surgical technique depends on the tumour’s location and stage.

Chemotherapy

Chemotherapy may be recommended after surgery when there is a significant risk that microscopic cancer cells remain.

For more advanced disease, chemotherapy may also be used to control the cancer, shrink tumours or relieve symptoms.

Radiotherapy

Radiotherapy has a particularly important role in certain rectal cancers.

Depending on the situation, radiation may be combined with chemotherapy before or after surgery.

Targeted Therapy

Cancer cells can contain specific molecular alterations that affect how they grow.

Modern testing can identify some of these biomarkers, allowing oncologists to select targeted medicines for suitable patients.

Immunotherapy

One of the most significant advances has been the use of immunotherapy for selected colorectal cancers.

Tumours with characteristics such as microsatellite instability-high (MSI-H) or mismatch repair deficiency (dMMR) may respond to certain immune-checkpoint therapies.

This is why molecular testing has become increasingly important in modern colorectal cancer management.

Does Every Young Adult Need a Colonoscopy?

No.

The rise in early-onset colorectal cancer does not mean every person in their 20s or 30s should automatically undergo a colonoscopy.

Screening recommendations depend on age, country-specific guidance, individual risk, family history and underlying medical conditions.

The important distinction is between screening and diagnostic evaluation.

Screening is performed in people without symptoms according to risk-based recommendations.

Diagnostic colonoscopy may be recommended at any appropriate age when symptoms or medical findings justify further investigation.

For someone with persistent rectal bleeding, unexplained iron-deficiency anaemia, significant bowel changes or other concerning symptoms, waiting until a routine screening age would make little sense.

Family History Changes the Conversation

Someone with a strong family history should tell their doctor exactly which relative developed colorectal cancer and at what age.

This information can materially change risk assessment.

Patients with hereditary cancer syndromes may require substantially earlier and more frequent surveillance than people at average risk. Indian guidance also recognises hereditary syndromes and family history as important considerations in colorectal cancer management.

Young Does Not Mean Zero Risk

The intention of discussing colorectal cancer in young adults is not to create fear around every digestive symptom.

Most stomach pain, constipation and rectal bleeding in younger adults will have causes other than cancer.

But the opposite assumption is also wrong:

“I am too young to have colorectal cancer.”

Current evidence shows that younger adults can develop the disease and that incidence is increasing in a number of populations worldwide.

Persistent symptoms deserve an explanation, not an assumption.

When Should You Consult a Gastroenterologist?

Consider gastroenterology evaluation if you experience recurrent or persistent rectal bleeding, a sustained change in bowel habits, unexplained anaemia, persistent abdominal symptoms, unexplained weight loss or digestive symptoms accompanied by a significant family history.

At DrGastro in Ahmedabad, patients with concerning lower-GI symptoms can undergo specialist assessment and, where medically appropriate, colonoscopy for evaluation of the colon and rectum.

If a biopsy confirms colorectal cancer, further treatment should be planned with the appropriate multidisciplinary cancer-care team, which may include colorectal surgeons, medical oncologists, radiation oncologists, gastroenterologists and other specialists depending on the case.

Conclusion

Colorectal cancer is still more common in older adults, but it can no longer be treated exclusively as an older person’s disease.

Changing incidence patterns, Indian clinical observations and emerging research into metabolic, lifestyle, genetic and microbiome-related factors are forcing medicine to look more closely at early-onset colorectal cancer.

For younger adults, the practical message is simple:

Do not panic about every digestive symptom, but do not repeatedly ignore persistent warning signs either.

Proper evaluation, timely colonoscopy when indicated and modern personalised treatment can make a substantial difference.